Mattsson Jan 4
4 · ALBIREO PHARMA, INC. · Filed Jan 25, 2022
Insider Transaction Report
Form 4
Mattsson Jan
Chief Operating Officer
Transactions
- Sale
Common Stock
2022-01-24$24.88/sh−808$20,105→ 58,366 total
Footnotes (3)
- [F1]Shares sold pursuant to a Rule 10b5-1 arrangement established in October 2019 to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.7811 to $24.97, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F3]Represents 32,641 shares of common stock and 25,725 restricted stock units.